Skip to main content
Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
10.97
-0.11 (-0.99%)
At close: Dec 20, 2024, 4:00 PM
11.67
+0.70 (6.38%)
After-hours: Dec 20, 2024, 4:03 PM EST

Immunome Revenue

Immunome had revenue of $2.91M in the quarter ending September 30, 2024, a decrease of -18.37%. This brings the company's revenue in the last twelve months to $10.13M, down -0.62% year-over-year. In the year 2023, Immunome had annual revenue of $14.02M.

Revenue (ttm)
$10.13M
Revenue Growth
-0.62%
P/S Ratio
58.08
Revenue / Employee
$184,164
Employees
55
Market Cap
684.71M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202314.02M--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Avanos Medical 681.50M
Bioventus 555.06M
Evolus 248.33M
Relay Therapeutics 10.01M
Dianthus Therapeutics 5.37M
Oculis Holding AG 1.03M
Keros Therapeutics 651.00K
Revenue Rankings

IMNM News

More News